Immusol Changes Name to ItherX, Names New CEO

Immusol Inc., a privately held biopharmaceutical company, announced that it has changed its name to ItherX Pharmaceuticals Inc. and has appointed Jeffrey F. McKelvy as President, Chief Executive Officer and Director.
BioSpace